• StemVax relies on cutting-edge research and
    creativity to face the unknown

  • Keeping dreams alive through immunotherapy

  • A new way of treating disease,
    stem cell immunology

Cutting-edge research & creativity to face the unknown
Keeping dreams alive
through immunotherapy
A new way of treating disease, stem cell immunology

Welcome

StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. We focus our efforts on developing immunotherapeutic approaches to treating patients with Glioblastoma Multiforme (GBM), a devastating brain cancer. We also focus our research efforts on novel drug development to target Cancer Stem cells and other multi-resistant cancer cells.

We seek to make a difference in patient’s lives. Bringing new beginnings to the market by developing novel therapeutics.

Events

StemVax has partnered with Softlayer an IBM company, Softlayer.com

StemVax participates in the National Brain Tumor Society 5K walk and sponsors over $1000.

StemVax participates in Keystone Symposia Conference on “The Modes of Action of Vaccine Adjuvants”

Faucibus oposuere cun olltvelit sed le pharuars elorta diaiiscing aliqIdaliquet sit amet euismod iuor ut ligu.